Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Dimethylfumarate induces apoptosis in human mast cells.
American Academy of Neurology Annual Meeting
National MS Society: Patient Management, Care and Rehabilitation Research Grants
ForuMS: A Virtual Journal Club for MS Clinicians
Plasma ubiquitin?proteasome system profile in patients with multiple sclerosis: correlation with clinical features, neuroimaging, and treatment with interferon-beta-1b.
PiB and other amyloid-PET tracers for the study of white matter and multiple sclerosis.
Neuromyelitis optica spectrum disorder (NMOSD): A new concept.
Imaging in Pediatric Demyelinating and Inflammatory Diseases of Brain- Part 2.
Recent insights into the mechanism of action of glatiramer acetate.
New data reinforce efficacy of TECFIDERA® (dimethyl fumarate) in MS patients with high disease activity
Qiagen Webinar: Molecular Mechanisms of Neurodegeneration
Mitoxantrone induces natural killer cell maturation in patients with secondary progressive multiple sclerosis.
An inhibitor of chondroitin sulfate proteoglycan synthesis promotes central nervous system remyelination.
Eosinophilic Fasciitis-like Disorder Developing in the Setting of Multiple Sclerosis Therapy.
Hyperforin-loaded gold nanoparticle alleviates experimental autoimmune encephalomyelitis by suppressing Th1 and Th17 cells and upregulating regulatory T cells.
Decreased systemic IL-7 and soluble IL-7Rα in multiple sclerosis patients.
Association between the three functional miR-146a single-nucleotide polymorphisms, rs2910164, rs57095329, and rs2431697, and autoimmune disease susceptibility: A meta-analysis.
The possible effects of the solar and geomagnetic activity on multiple sclerosis.
Persistence with and adherence to fingolimod compared with other disease-modifying therapies for the treatment of multiple sclerosis: a retrospective US claims database analysis.
Three-Month Test-Retest Reliability of Center of Pressure Motion During Standing Balance in Individuals with Multiple Sclerosis.
Biogen slips as FDA extends review of MS drug
European/Canadian multicenter, double-blind, randomized, placebo-controlled study of the effects of glatiramer acetate on magnetic resonance imaging--measured disease activity and burden in patients with relapsing multiple sclerosis.
Rebif approval application
Keystone Symposium: T Cells: Regulation and Effector Function
A monoclonal natural human IgM protects axons in the absence of remyelination.
Pages
« first
‹ previous
…
68
69
70
71
72
73
74
75
76
…
next ›
last »